Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
1997/04/01 by Gareth Jones, Peter Willett, Robert C Glen +4 · 71 citations
Computer Science · Biochemistry, Genetics and Molecular Biology · Chemistry · #Computational Drug Discovery Methods #Protein Degradation and Inhibitors #Click Chemistry and Applications
paper · doi:10.1006/jmbi.1996.0897
Citations
Cited by
- Design, Syntheses, and Pharmacological Evaluations of Core Ring Expanded Fentanyl Analogues as Potential Counteracting Agents Against Fentanyl Induced Respiratory Depression
- Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight
- Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
- Computational Methods in Drug Discovery
- The Need for Continuing Blinded Pose- and Activity Prediction Benchmarks
- CORAL: Learning Amyloid Fibril Ligand Docking with Cooperative Binding Rewards
- Molecular analysis of DHFR and DHPS gene mutations in Plasmodium cynomolgi from humans and macaques in Southeast Asia
- Flexible docking using tabu search and an empirical estimate of binding affinity
- Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search
- Variability in docking success rates due to dataset preparation
- Omega‐3 DHA as a blank canvas: A molecular approximation to how lipid mediators modulate LGR6 in inflammation resolution
- Novel Triazolopyrimidinone Compounds as Inhibitors of Adipocyte Fatty Acid–Binding Protein (FABP4)
- A new Lamarckian genetic algorithm for flexible ligand‐receptor docking
- Sulfur metabolism under stress: Oxidized glutathione inhibits methionine biosynthesis by destabilizing the enzyme cystathionine γ‐synthase
- Small-Molecule CD4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp120
- AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings
- Comparative Analysis of Quantum-Mechanical and Standard Single-Structure Protein–Ligand Scoring Functions with MD-Based Free Energy Calculations
- MathDL: Mathematical deep learning for D3R Grand Challenge 4
- CADD, AI and ML in drug discovery: A comprehensive review
- Unveiling an unexpected redox regulation of the folding, function and inhibition in the phosphotyrosine binding domain of FRS2
- FLOWR.root: A flow matching based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction
- Similar but Distinct—Biochemical Characterization of the Staphylococcus aureus Serine Hydrolases FphH and FphI
- Biological properties and in silico studies of thiazolopyrimidine derivatives active against visceral and cutaneous Leishmania spp. amastigote forms
- Copper(II) benzyloxychalcone analogues as new potential metallodrugs against SARS-CoV-2 replication
- Revisiting the halogen bonding between phosphodiesterase type 5 and its inhibitors
- An artificial intelligence accelerated virtual screening platform for drug discovery
- Speciation and structural transformation of a V V –malate complex in the absence and in the presence of a protein: from a dinuclear species to decavanadate
- C1′‐Branched Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium Falciparum 6‐Oxopurine Phosphoribosyltransferase
- A workflow to create a high-quality protein–ligand binding dataset for training, validation, and prediction tasks
- SwissParam: A fast force field generation tool for small organic molecules
- Nitrile-based peptoids as cysteine protease inhibitors
- General and targeted statistical potentials for protein–ligand interactions
- Enhancing Ligand Pose Sampling for Molecular Docking
- PoseBusters: AI-based docking methods fail to generate physically valid poses or generalise to novel sequences
- SparseMap: A Sparse Tensor Accelerator Framework Based on Evolution Strategy
- eSylites: Synthetic Probes for Visualization and Topographic Mapping of Single Excitatory Synapses
- Exploiting the synergy between computational and experimental biophysics for efficient cancer drug development
- Leak Proof PDBBind: A Reorganized Dataset of Protein-Ligand Complexes for More Generalizable Binding Affinity Prediction
- SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management
- Novel Flavonoid Derivatives Show Potent Efficacy in Human Lymphoma Models
- Developments in molecular docking technologies for application of polysaccharide-based materials: A review
- A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios
- Generative network complex (GNC) for drug discovery
- Structural Studies of Cinnamoyl-CoA Reductase and Cinnamyl-Alcohol Dehydrogenase, Key Enzymes of Monolignol Biosynthesis
- Modeling defensive functions of alkaloids within diverse chemical portfolios
- Sequence-based prediction of function site and protein-ligand interaction by a functionally annotated domain profile database
- New insights into the antiviral effects of chloroquine. [europepmc]
- Virtual ligand screening: strategies, perspectives and limitations. [europepmc]
- Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy. [europepmc]
- Validation of molecular docking programs for virtual screening against dihydropteroate synthase. [europepmc]
- Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. [europepmc]
- A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking. [europepmc]
- Scoring functions and their evaluation methods for protein-ligand docking: recent advances and future directions. [europepmc]
- Molecular docking: a powerful approach for structure-based drug discovery. [europepmc]
- Structure-based virtual screening for drug discovery: a problem-centric review. [europepmc]
- Variability in docking success rates due to dataset preparation. [europepmc]
- Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. [europepmc]
- Computational methods in drug discovery. [europepmc]
- Structure-based virtual screening for drug discovery: principles, applications and recent advances. [europepmc]
- Molecular docking and structure-based drug design strategies. [europepmc]
- Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods. [europepmc]
- Software for molecular docking: a review. [europepmc]
- Binding Affinity via Docking: Fact and Fiction. [europepmc]
- Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview. [europepmc]
- Ultra-large library docking for discovering new chemotypes. [europepmc]
- CB-Dock: a web server for cavity detection-guided protein-ligand blind docking. [europepmc]
- Key Topics in Molecular Docking for Drug Design. [europepmc]
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo. [europepmc]
- AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. [europepmc]
- A practical guide to large-scale docking. [europepmc]
- PoseBusters: AI-based docking methods fail to generate physically valid poses or generalise to novel sequences. [europepmc]